216 related articles for article (PubMed ID: 33021723)
1. Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model.
Delaye JB; Lanznaster D; Veyrat-Durebex C; Fontaine A; Bacle G; Lefevre A; Hergesheimer R; Lecron JC; Vourc'h P; Andres CR; Maillot F; Corcia P; Emond P; Blasco H
Neurotherapeutics; 2021 Jan; 18(1):297-308. PubMed ID: 33021723
[TBL] [Abstract][Full Text] [Related]
2. Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.
Patin F; Baranek T; Vourc'h P; Nadal-Desbarats L; Goossens JF; Marouillat S; Dessein AF; Descat A; Hounoum BM; Bruno C; Watier H; Si-Tahar M; Leman S; Lecron JC; Andres CR; Corcia P; Blasco H
Neurotherapeutics; 2016 Oct; 13(4):905-917. PubMed ID: 27444617
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1
Xu X; Yang Q; Liu Z; Zhang R; Yu H; Wang M; Chen S; Xu G; Shao Y; Le W
Neurobiol Dis; 2023 Jun; 181():106110. PubMed ID: 37001614
[TBL] [Abstract][Full Text] [Related]
5. Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism.
Patin F; Corcia P; Vourc'h P; Nadal-Desbarats L; Baranek T; Goossens JF; Marouillat S; Dessein AF; Descat A; Madji Hounoum B; Bruno C; Leman S; Andres CR; Blasco H
Mol Neurobiol; 2017 Sep; 54(7):5361-5374. PubMed ID: 27590138
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Petri S; Kipiani K; Gardian G; Choi DK; Chen J; Calingasan NY; Schafer P; Muller GW; Stewart C; Hensley K; Beal MF
J Neurosci; 2006 Mar; 26(9):2467-73. PubMed ID: 16510725
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
8. Glucose clearance and uptake is increased in the SOD1
McDonald TS; Kumar V; Fung JN; Woodruff TM; Lee JD
FASEB J; 2021 Jul; 35(7):e21707. PubMed ID: 34118098
[TBL] [Abstract][Full Text] [Related]
9. Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.
Neymotin A; Petri S; Calingasan NY; Wille E; Schafer P; Stewart C; Hensley K; Beal MF; Kiaei M
Exp Neurol; 2009 Nov; 220(1):191-7. PubMed ID: 19733563
[TBL] [Abstract][Full Text] [Related]
10. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
11. Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1
Chiarotto GB; Cartarozzi LP; Perez M; Biscola NP; Spejo AB; Gubert F; França Junior M; Mendez-Otero R; de Oliveira ALR
J Neuroinflammation; 2019 Nov; 16(1):218. PubMed ID: 31727149
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
13. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
[TBL] [Abstract][Full Text] [Related]
15. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
Bette M; Cors E; Kresse C; Schütz B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328829
[TBL] [Abstract][Full Text] [Related]
17. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
18. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Lei H; Dirren E; Poitry-Yamate C; Schneider BL; Gruetter R; Aebischer P
J Cereb Blood Flow Metab; 2019 Jul; 39(7):1283-1298. PubMed ID: 29400109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
